China NMPA Inspection - Shenzhen SMA Instruments Co., Ltd. - January 21, 2020

The National Medical Products Administration (NMPA) announced on January 21, 2020, a mandatory suspension of production and requirement for rectification for Shenzhen SMA Instruments Co., Ltd. This regulatory action, formalized under Announcement No. 8 of 2020, indicates that the company must cease its manufacturing operations and implement comprehensive corrective measures. While the specific violations leading to this directive are not detailed in the announcement, the NMPA's action underscores the necessity for Shenzhen SMA Instruments Co., Ltd. to address identified issues and ensure full compliance with regulatory standards before resuming production. This measure reflects the NMPA's commitment to overseeing product quality and safety within its jurisdiction.